Brentuximab Vedotin

About Medicine

  • Generic Name: Brentuximab Vedotin
  • Strength: 50 mg
  • Packing: Single Vial
Get Price

Description

Brentuximab Uses

Brentuximab vedotin is a CD30 directed antibody drug conjugate used for the treatment of patients with: Hodgkin lymphoma after unsuccessful autologous stem cell transplant (ASCT) or after at least two prior unsuccessful multi-agent chemotherapy regimens in those who are not ASCT candidates. Systemic anaplastic large cell lymphoma after at least one prior unsuccessful multi-agent chemo regimen.

Dosage: The recommended dose of brentuximab vedotin is 1.8 mg/kg, which must be administered as an intravenous infusion over 30 minutes every 3 weeks. Reduce dose in patients with mild hepatic impairment. The treatment should be continued until disease is progressive or unacceptable toxicity occurs.

Side Effects: The most commonly reported brentuximab vedotin side effects include:

  • Neutropenia
  • Fatigue
  • Nausea
  • Anemia
  • Diarrhea
  • Pyrexia
  • Rash
  • Thrombocytopenia
  • Cough
  • Vomiting
  • Peripheral sensory neuropathy
  • Upper respiratory tract infection

Warnings and Precautions:

  • Monitor patients with brentuximab dosage for symptoms of neuropathy, such as hyperesthesia, hypoesthesia, paresthesia, a burning sensation, discomfort, neuropathic pain, or weakness.
  • Cases of infusion-related reactions, including anaphylaxis, have occurred with brentuximab therapy. Patients should be monitored during infusion.
  • Avoid conceiving pregnancy during brentuximab 50 mg treatment. Appropriate contraceptive precautions should be considered.
  • Do not breastfeed while taking this medication.
  • Do not take any vaccination or immunization, aspirin or any other product containing Aspirin without a healthcare professional’s approval.

More info

Storage: Store the vials of brentuximab 50 mg at temperature 2°C to 8°C (36°F to 46°F) in the original carton in order to protect from light. Availability in India: The Indian Pharma helps connect buyers with suppliers who can ship the Brentuximab at the global level as per the needs of buyer’s. The Indian Pharma provides guarantee of quality as well as delivery for the Brentuximab Injections. Buying Procedure: To buy Brentuximab, you can contact us at our Toll-free number 1800 889 1064 or on WhatsApp +919650877511 or an Email to us at: info@theindianpharma.com along with the legitimate ID Proof, standard Prescription and Medical Reports. Conclusion: Brentuximab vedotin is one of the promising targeted therapy in the treatment of Hodgkin lymphoma. It is injected intravenously and rarely causes side effects.

FAQ

What is Brentuximab vedotin?

Brentuximab vedotin is an antibody-drug conjugate for the treatment of patients with relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL).

How is Brentuximab vedotin supplied?

Brentuximab vedotin is supplied as a single vial of 50 mg for intravenous administration.

How much does brentuximab cost?

Brentuximab can only be imported after taking approval from the Drug Controller’s office. The cost /price of Brentuximab depends on the USD/EURO conversion price. It is illegal to sell Brentuximab Vedotin in cash in India. Brentuximab is available as a single vial of 50 mg. There is no generic or bio-similar for this product.

What is the best price for Brentuximab?

Please contact Toll-free: +91 1800 889 1064|+919650877511 for brentuximab price in India. We take the guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Can I get Brentuximab vedotin 50mg even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Indian Pharma helps patients in accessing or importing Brentuximab vedotin 50mg, not approved in their home country against the legitimate prescription and in conformity with the all local laws and regulations of their home country.

What is Named Patient Program?

New medicines which have been approved recently in USA or Europe but not yet approved in India or Rest of the world countries cannot be permitted to import or market commercially. However, they may be required for the treatment of some patients to save their lives who have exhausted all other available treatment options in their home country. Named – Patient Program is facilitate import of such medicines for personal use. There is a provision under the Indian Drugs and Cosmetics Rules, 1945, which permits needy patient to import these medicine for personal use in smaller quantities. Similar regulatory provision also exist in other countries as well. We help such patient in preparing legal documents for import and connecting them with genuine suppliers to secure genuine products.

Documentation

What information do you need to help the patient in assisting documentation for Brentuximab import for personal use?

We will require the following documents to help in documentation for Named-Patient import
  • Doctor’s Prescription – We would require a prescription from a Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
  • Patient’s Medical history – We would require all test reports and Medical reports of the patient for the last 3 months.
  • Patient’s Identity card – We will require a scanned copy of the Patient’s identity card and proof of residence to initiate the documentation process. You can use a copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.

×